Feb 2009
Enzo Life Sciences, a recognized leader in labeling and detection technologies for the life science research and diagnostic markets, has significantly enhanced its already comprehensive capabilities and product offerings with the acquisitions of ALEXIS® Biochemicals and BIOMOL® International. The resulting organization boasts a portfolio of over 8,000 biochemical and biological reagents for the research community along with 30+ years of skill, innovation, and experience in life science reagent development. Researchers worldwide can now purchase all of these products through one source: Enzo Life Sciences.
Building on the foundations of its strong brands — ALEXIS® Biochemicals, BIOMOL® International, and ENZO® — Enzo Life Sciences provides researchers with easy, worldwide access to a comprehensive portfolio of reagents and technical support for genomic analysis, post-translational modification, cancer and immunology, cellular analysis, signal transduction, and drug discovery applications. The company also offers a full range of custom services, including peptide synthesis, antibody production, protein expression, organic synthesis, and custom-labeled FISH probes.
More information on these products is available on-line at their website: www.enzolifesciences.com, or to receive more technical product information, e-mail, phone 610-941-0430, or write Enzo Life Sciences, Inc. at 5120 Butler Pike, Plymouth, PA 19462 USA.
